文献速递慢阻肺

COPD健康状况工具的临床相关差异:系统综述与三角整合

Clinically relevant differences in COPD health status: systematic review and triangulation.
PubMed 文献 · Eur Respir J · 2018-09-06

该系统综述通过检索PubMed、EMBASE和Cochrane Library,纳入21项研究,对12种COPD健康状况工具的MCID进行三角整合。CAT、CCQ和SGRQ的三角整合MCID(改善方向)分别为-2.54、-0.43和-7.43。目前临床使用的SGRQ(4)和CRQ(0.5)的MCID与综述内容不匹配,MCID偏低可能高估治疗效果。

要点

  • CAT和CCQ的MCID证据强且三角整合有效。
  • SGRQ和CRQ现行MCID与综述结果不匹配,实际MCID更高。
  • 恶化方向的MCID研究匮乏,需更多研究。

核心结论

  • CAT和CCQ的MCID证据强且三角整合有效。
  • SGRQ(4)和CRQ(0.5)的现行MCID与综述内容不匹配,其MCID远高于现行值。
  • 使用过低的MCID可能导致对治疗效应解读的高估。
  • 恶化方向的MCID研究稀缺,需更多研究。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和Cochrane Library(Prospero #CRD42015023221)。
  • 共审查785条记录,最终纳入21项研究进行分析。
  • 由两名作者评估并提取研究细节、患者特征、MCID方法和估计值。
  • 对每种工具的MCID进行三角整合均值计算:锚定法权重三分之二,分布法权重三分之一,再乘以基于研究规模和质量评级的加权因子。

主要发现

  • 共呈现12种工具的MCID。
  • 总体质量和偏倚风险为平均至良好。
  • CAT、CCQ和SGRQ的三角整合MCID(改善方向)分别为-2.54、-0.43和-7.43。
  • 其他工具的MCID因研究过少和/或过于多样而无法进行三角整合。

关键数值与推荐

  • CAT的三角整合MCID(改善)为-2.54。
  • CCQ的三角整合MCID(改善)为-0.43。
  • SGRQ的三角整合MCID(改善)为-7.43。
  • 目前临床使用的SGRQ MCID为4,CRQ MCID为0.5,与综述内容不匹配,其MCID远高于现行值。

临床怎么用

  • 临床解读COPD健康状况工具的治疗效应时,应参考三角整合的MCID值。
  • 避免使用过低的MCID,以防高估治疗效果。
  • 对SGRQ和CRQ,现行MCID可能偏低,需注意其实际临床相关性阈值更高。

局限性

  • 其他工具的MCID因研究过少和/或过于多样而无法进行三角整合。
  • 恶化方向的MCID研究稀缺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The minimal clinically important difference (MCID) quantifies when measured differences can be considered clinically relevant. This study aims to review and triangulate MCIDs of chronic obstructive pulmonary disease (COPD) health status tools.A systematic search in PubMed, EMBASE and Cochrane Library was conducted (Prospero #CRD42015023221). Study details, patient characteristics, MCID methodology and estimates were assessed and extracted by two authors. A triangulated mean was obtained for each tool's MCID, with two-thirds weighting for anchor-based and one-third for distribution-based results. This was then multiplied by a weighted factor based upon the study size and quality rating.Overall, 785 records were reviewed of which 21 studies were included for analysis. MCIDs of 12 tools were presented. General quality and risk of bias were average to good. Triangulated MCIDs for the COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ) and St. George's Respiratory Questionnaire (SGRQ) were -2.54, -0.43 and -7.43 for improvement. Too few and/or too diverse studies were present to triangulate MCIDs of other tools.Evidence for the MCID of the CAT and CCQ was strong and triangulation was valid. Currently used MCIDs in clinical practice for the SGRQ (4) and Chronic Respiratory Questionnaire (0.5) did not match the reviewed content, for which the MCIDs were much higher. Using too low MCIDs may lead to an overestimation of the interpretation of treatment effects. MCIDs for deterioration were scarce, which highlights the need for more research.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Alma H, de Jong C, Tsiligianni I, et al. Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J. 2018. PMID: 30139774. doi:10.1183/13993003.00412-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。